In the pharmaceutical industry, universities appear to have found a partner willing and able to buy big chunks of their research. Beyond making drugs, however, such big-dollar corporate alliances remain rare.
Office of Strategic Communication
In the pharmaceutical industry, universities appear to have found a partner willing and able to buy big chunks of their research. Beyond making drugs, however, such big-dollar corporate alliances remain rare.